新闻Recordati Rare Diseases Inc. acquired EUSA Pharma Ltd on Jan 1st '22.Recordati, which acquired Eusa in 2022, now sells the drug.
新闻Recordati S.p.A. acquired EUSA Pharma Ltd for $824M on Mar 1st '22.In March 2022, Recordati S.p.A., an Italy-based pharmaceutical group, acquired EUSA Pharma (UK) Ltd. for $824.28 million.
新闻Emma leaves EUSA Pharma Ltd as Chief Financial Officer.Emma joins Essential Pharma from EUSA Pharma, where she was co-founder and served as Chief Financial Officer for more than seven years.
